Blood Culture Tests Market - Global Outlook & Forecast 2024-2029
Market Report I 2024-05-16 I 318 Pages I Arizton Advisory & Intelligence
The global blood culture tests market is expected to grow at a CAGR of 7.81% from 2023 to 2029.
MARKET OPPORTUNITIES & TRENDS
Rising Development with Automated Blood Culture Test Systems
The automated blood culture test systems are a ray of hope in the blood culture tests market to increase the speed of diagnosis and reduce contamination rate. With the rising demand for rapid diagnosis of blood-associated and other infectious diseases, the requirement for advanced blood culture test systems is rapidly increasing across the market. These advanced systems are intended to make blood culture processing more efficient and streamlined, as stated by the National Library of Medicine Report 2021. Also, these systems reduce the demand for terminal or blind subculture bottles and increase the speed of test procedures. These systems are effective and efficient and increase blood culture test specificity and sensitivity; these factors are expected to deliver new market growth opportunities.
Advances in Blood Culture Testing
The development and innovation of new technologies for blood culture testing are accelerating the blood culture tests market growth. Bloodstream diseases are a significant cause of severe health outcomes and death with growing incidence and severity. A general blood culture test is the standard method; however, the upcoming new technologies and advances, such as molecular-based diagnostics, are used as add-on complementary assays. It increases test speed and speed-up microbial detection and guesses antimicrobial susceptibility. Furthermore, innovations for blood culture testing, such as molecular testing technologies, are more accurate and sensitive than traditional methods. In the past few years, diagnosing bloodstream infections has relied on time-consuming basic blood cultures and traditional organism identification and susceptibility testing. Technologies to define the culprit in bloodstream infections have gained sophistication in recent years, notably by applying molecular diagnostic methods.
Growing Demand for Early & Preventive Diagnosis
Globally, the rising concern about health drives the demand for early disease diagnosis, positively influencing the blood culture tests market growth. The accurate and early diagnosis of diseases is essential to prevent wasting patients' valuable time on the wrong course of treatments. When a patient gets an accurate diagnosis, it offers the best opportunities for positive health outcomes with the help of clinical decisions tailored to a correct understanding of the patient's health issues. Bloodstream infections, specifically sepsis, are highly demanded for early and preventive diagnosis. Several government initiatives and healthcare policies favor early sepsis and other bloodstream infections. Also, the growing importance of accurate diagnosis is the leading factor accelerating the preference for blood culture tests in infectious disease management. Medical errors are one of the leading causes of death worldwide and were one of the leading causes of death in the U.S. in the past few years. The growing importance of accurate diagnosis of infectious diseases is accelerating visits to clinical laboratories and boosting the demand for blood culture tests and associated equipment and consumables.
SEGMENTATION INSIGHTS
INSIGHTS BY SAMPLE TYPE
The global blood culture tests market by sample type is segmented into bacterial and non-bacterial samples. During the forecast period, the bacterial sample type segment accounted for the highest market share and dominated the market. Bacterial pathogens are significantly prevalent in bloodstream infections compared to other pathogens. Bacterial pathogens severely impact human health and drive the demand for early and preventive diagnosis, where the bacterial sample is commonly used in blood culture testing and accelerates segmental growth.
Segmentation by Sample Type
- Bacterial Sample
- Non-bacterial Sample
INSIGHTS BY METHOD
The global blood culture tests market by method is segmented into manual/conventional blood culture and automated blood culture. Manual/conventional blood culture methods are traditional and familiar to lab operators. These methods are used longer, giving them high popularity and acceptance. In 2023, the manual/conventional blood culture method segment accounted for the largest share of the market. Manual/conventional blood culture methods are commonly used due to the convenience and affordability of required solutions. Conversely, automated blood culture methods are becoming more popular in recent years. The automation in sample processing gives high efficacy, resulting in the best delivery result. Also, automated blood culture systems are becoming more popular and the primary choice to identify pathogens from blood samples. Rather than manually reading broth-based conventional methods, labs now use continuously monitored automated systems to process blood culture samples.
Segmentation by Method
- Manual/Conventional Blood Culture
- Automated Blood Culture
INSIGHTS BY PRODUCT
The consumables product segment holds the most significant share of the global blood culture tests market 2023. Consumables are in high demand due to their repetitive use in blood culture testing at all diagnostic laboratories and research centers. Also, some consumables can be used only once and must be discarded or replaced after some time. It increases the application rate and demand for consumables over test equipment. Further, the consumables include a range of solutions used in general to standard laboratories, which include reagents, filters, tubes, plates, and gloves. These consumables are commonly in demand in hospitals, life sciences, academic laboratories, etc.
Segmentation by Product
- Consumables
- Test Equipment
INSIGHTS BY END-USERS
The global blood culture tests market by end-users is segmented into hospital-based laboratories, clinical laboratories, academic and research laboratories/centers, and others. The hospital-based laboratories segment accounted for over 45% of the highest market share in 2023. Blood culture tests are commonly performed in hospital-associated laboratory centers due to a significant patient population with infectious diseases and a higher prevalence of bloodstream infection in hospital settings. Hospital-acquired infections and associated risks commonly require blood culture tests and significantly contribute to segmental revenue growth.
Segmentation by End-users
- Hospital-based Laboratories
- Clinical Laboratories
- Academic & Research Laboratories/Centers
- Others
GEOGRAPHICAL ANALYSIS
North America holds the largest share of the global blood culture tests market, accounting for a global revenue share of 35% in 2023. The region holds a significant market share due to the increasing burden of bloodstream infection across hospital settings, the rising burden of sepsis management, and the growing awareness and acceptance of automated blood culture systems. In addition, the presence of major market players in the U.S. accelerates the influencing demand and adoption of blood culture test equipment and consumables, fueling market growth.
APAC is expected to witness the highest CAGR in the global blood culture tests market during the forecast period. The market growth in APAC is anticipated with the increasing burden of infectious diseases, such as bloodstream infection, sepsis, hospital-associated infection, and others. In addition, the rapid development in healthcare and life sciences is accelerating market growth. China and India are the two leading countries that have witnessed increasing development in the diagnostics field for preventive measures, and early diagnosis of infectious diseases is expected to drive significant market growth in these countries.
Segmentation by Geography
- North America
o The U.S.
o Canada
- Europe
o Germany
o France
o The U.K.
o Italy
o Spain
o Russia
o Poland
- APAC
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
- Latin America
o Brazil
o Mexico
o Argentina
- Middle East & Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
VENDOR LANDSCAPE
Vendors can understand that the traditional blood culture test methods are the most used method over automated blood culture systems, where the automated systems are becoming a new ray of hope in the blood culture tests market. Vendors can develop advanced automated blood culture systems and achieve revenue growth opportunities. Furthermore, globally, bloodstream infection (BSI) and sepsis cases are most commonly reported in healthcare settings, where the demand for blood culture tests is continuously rising and is expected to deliver huge revenue growth opportunities.
Very few automated blood culture test systems are available, and their acceptance is rising steadily in the market, which is a significant opportunity for vendors to develop new solutions. Also, there has been a slow shift from manual to automated blood culture test methods, where vendors can focus on increasing their market penetration by launching new automated systems.
Key Company Profiles
- BD
- BIOMERIEUX
- Bruker
- Danaher
- Terumo Corporation
- Thermo Fisher Scientific
Other Prominent Vendors
- Abbott
- Autobio
- Axiom
- Biolab Scientific
- Cardinal Health
- DiaSorin S.p.A.
- F. Hoffmann-La Roche
- Hardy Diagnostics
- HiMedia Laboratories
- ITL BioMedical
- Kurin Inc
- Labotronics Scientific
- Meditech Technologies India Private Limited
- OpGen
- Render Biotech Co., Ltd.
- SARSTEDT AG & Co KG
- Siemens Healthineers AG
- Scenker Biological Technology Co., Ltd
- T2 Biosystems (T2Bio)
KEY QUESTIONS ANSWERED:
1. How big is the blood culture tests market?
2. Which region dominates the global blood culture tests market share?
3. What are the significant trends in the blood culture tests market?
4. What is the growth rate of the global blood culture tests market?
5. Who are the global blood culture test market's key players?
1 SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. SEGMENTS COVERED & DEFINITION
1.2.1. MARKET BY SAMPLE TYPE
1.2.2. MARKET BY METHOD
1.2.3. MARKET BY PRODUCT
1.2.4. MARKET BY END-USER
1.2.5. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. HISTORIC, BASE, & FORECAST YEARS
2 PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
2.2.1. MARKET OPPORTUNITIES & TRENDS
2.2.2. MARKET DRIVERS/ENABLERS
2.2.3. MARKET SEGMENTATION
2.2.4. MARKET INSIGHTS
3 MARKET AT A GLANCE
4 INTRODUCTION
4.1. OVERVIEW
5 MARKET OPPORTUNITIES & TRENDS
5.1. GROWTH & DEVELOPMENT IN BLOOD CULTURE PATHWAY
5.2. RISING DEVELOPMENT WITH AUTOMATED BLOOD CULTURE TEST SYSTEMS
5.3. ADVANCES IN BLOOD CULTURE TESTING
6 MARKET GROWTH ENABLERS
6.1 INCREASE IN PREVALENCE OF SEPSIS
6.2 RISE IN BURDEN OF BLOODSTREAM INFECTIONS
6.3 INCREASE IN DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
7 MARKET RESTRAINTS
7.1 CONTAMINATION IS MAJOR CHALLENGE FOR BLOOD CULTURE TESTS
7.2 FALSE POSITIVE & NEGATIVE ERRORS AND ASSOCIATED IMPACTS
7.3 ALTERNATIVES TO BLOOD CULTURE TESTS
8 MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.2.1. MARKET BY SAMPLE TYPE
8.2.2. MARKET BY METHOD
8.2.3. MARKET BY PRODUCT
8.2.4. MARKET BY END-USER
8.2.5. MARKET BY GEOGRAPHY
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9 SAMPLE TYPE
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. BACTERIAL SAMPLE
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. MARKET BY GEOGRAPHY
9.4. NON-BACTERIAL SAMPLE
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. MARKET BY GEOGRAPHY
10 METHOD
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. MANUAL/CONVENTIONAL BLOOD CULTURE
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. MARKET BY GEOGRAPHY
10.4. AUTOMATED BLOOD CULTURE
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MARKET BY GEOGRAPHY
11 PRODUCT
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. CONSUMABLES
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. MARKET BY GEOGRAPHY
11.4. TEST EQUIPMENT
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. MARKET BY GEOGRAPHY
12 END-USER
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. HOSPITAL-BASED LABORATORIES
12.3.1. MARKET OVERVIEW
12.3.2. MARKET SIZE & FORECAST
12.3.3. MARKET BY GEOGRAPHY
12.4. CLINICAL LABORATORIES
12.4.1. MARKET OVERVIEW
12.4.2. MARKET SIZE & FORECAST
12.4.3. MARKET BY GEOGRAPHY
12.5. ACADEMIC & RESEARCH LABORATORIES/CENTERS
12.5.1. MARKET OVERVIEW
12.5.2. MARKET SIZE & FORECAST
12.5.3. MARKET BY GEOGRAPHY
12.6. OTHERS
12.6.1. MARKET OVERVIEW
12.6.2. MARKET SIZE & FORECAST
12.6.3. MARKET BY GEOGRAPHY
13 GEOGRAPHY
13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. GEOGRAPHIC OVERVIEW
14 NORTH AMERICA
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.3. SAMPLE TYPE
14.3.1. MARKET SIZE & FORECAST
14.4. METHOD
14.4.1. MARKET SIZE & FORECAST
14.5. PRODUCT
14.5.1. MARKET SIZE & FORECAST
14.6. END-USER
14.6.1. MARKET SIZE & FORECAST
14.7. KEY COUNTRIES
14.7.1. US: MARKET SIZE & FORECAST
14.7.2. CANADA: MARKET SIZE & FORECAST
15 EUROPE
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.3. SAMPLE TYPE
15.3.1. MARKET SIZE & FORECAST
15.4. METHOD
15.4.1. MARKET SIZE & FORECAST
15.5. PRODUCT
15.5.1. MARKET SIZE & FORECAST
15.6. END-USER
15.6.1. MARKET SIZE & FORECAST
15.7. KEY COUNTRIES
15.7.1. GERMANY: MARKET SIZE & FORECAST
15.7.2. FRANCE: MARKET SIZE & FORECAST
15.7.3. UK: MARKET SIZE & FORECAST
15.7.4. ITALY: MARKET SIZE & FORECAST
15.7.5. SPAIN: MARKET SIZE & FORECAST
15.7.6. RUSSIA: MARKET SIZE & FORECAST
15.7.7. POLAND: MARKET SIZE & FORECAST
16 APAC
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.3. SAMPLE TYPE
16.3.1. MARKET SIZE & FORECAST
16.4. METHOD
16.4.1. MARKET SIZE & FORECAST
16.5. PRODUCT
16.5.1. MARKET SIZE & FORECAST
16.6. END-USER
16.6.1. MARKET SIZE & FORECAST
16.7. KEY COUNTRIES
16.7.1. CHINA: MARKET SIZE & FORECAST
16.7.2. INDIA: MARKET SIZE & FORECAST
16.7.3. JAPAN: MARKET SIZE & FORECAST
16.7.4. SOUTH KOREA: MARKET SIZE & FORECAST
16.7.5. AUSTRALIA: MARKET SIZE & FORECAST
16.7.6. INDONESIA: MARKET SIZE & FORECAST
17 LATIN AMERICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.3. SAMPLE TYPE
17.3.1. MARKET SIZE & FORECAST
17.4. METHOD
17.4.1. MARKET SIZE & FORECAST
17.5. PRODUCT
17.5.1. MARKET SIZE & FORECAST
17.6. END-USER
17.6.1. MARKET SIZE & FORECAST
17.7. KEY COUNTRIES
17.7.1. BRAZIL: MARKET SIZE & FORECAST
17.7.2. MEXICO: MARKET SIZE & FORECAST
17.7.3. ARGENTINA: MARKET SIZE & FORECAST
18 MIDDLE EAST & AFRICA
18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.3. SAMPLE TYPE
18.3.1. MARKET SIZE & FORECAST
18.4. METHOD
18.4.1. MARKET SIZE & FORECAST
18.5. PRODUCT
18.5.1. MARKET SIZE & FORECAST
18.6. END-USER
18.6.1. MARKET SIZE & FORECAST
18.7. KEY COUNTRIES
18.7.1. TURKEY: MARKET SIZE & FORECAST
18.7.2. SAUDI ARABIA: MARKET SIZE & FORECAST
18.7.3. SOUTH AFRICA: MARKET SIZE & FORECAST
18.7.4. UAE: MARKET SIZE & FORECAST
19 COMPETITIVE LANDSCAPE
19.1. COMPETITION OVERVIEW
19.2. MARKET SHARE ANALYSIS
19.2.1. BD
19.2.2. BIOMERIEUX
19.2.3. BRUKER
19.2.4. DANAHER
19.2.5. TERUMO CORPORATION
19.2.6. THERMO FISHER SCIENTIFIC
20 KEY COMPANY PROFILES
20.1. BD
20.1.1. BUSINESS OVERVIEW
20.1.2. PRODUCT OFFERINGS
20.1.3. KEY STRATEGIES
20.1.4. KEY STRENGTHS
20.1.5. KEY OPPORTUNITIES
20.2. BIOMERIEUX
20.2.1. BUSINESS OVERVIEW
20.2.2. PRODUCT OFFERINGS
20.2.3. KEY STRATEGIES
20.2.4. KEY STRENGTHS
20.2.5. KEY OPPORTUNITIES
20.3. BRUKER
20.3.1. BUSINESS OVERVIEW
20.3.2. PRODUCT OFFERINGS
20.3.3. KEY STRATEGIES
20.3.4. KEY STRENGTHS
20.3.5. KEY OPPORTUNITIES
20.4. DANAHER
20.4.1. BUSINESS OVERVIEW
20.4.2. PRODUCT OFFERINGS
20.4.3. KEY STRATEGIES
20.4.4. KEY STRENGTHS
20.4.5. KEY OPPORTUNITIES
20.5. TERUMO CORPORATION
20.5.1. BUSINESS OVERVIEW
20.5.2. PRODUCT OFFERINGS
20.5.3. KEY STRATEGIES
20.5.4. KEY STRENGTHS
20.5.5. KEY OPPORTUNITIES
20.6. THERMO FISHER SCIENTIFIC
20.6.1. BUSINESS OVERVIEW
20.6.2. PRODUCT OFFERINGS
20.6.3. KEY STRATEGIES
20.6.4. KEY STRENGTHS
20.6.5. KEY OPPORTUNITIES
21 OTHER PROMINENT VENDORS
21.1. ABBOTT
21.1.1. BUSINESS OVERVIEW
21.1.2. PRODUCT OFFERINGS
21.2. AUTOBIO
21.2.1. BUSINESS OVERVIEW
21.2.2. PRODUCT OFFERINGS
21.3. AXIOM
21.3.1. BUSINESS OVERVIEW
21.3.2. PRODUCT OFFERINGS
21.4. BIOLAB SCIENTIFIC
21.4.1. BUSINESS OVERVIEW
21.4.2. PRODUCT OFFERINGS
21.5. CARDINAL HEALTH
21.5.1. BUSINESS OVERVIEW
21.5.2. PRODUCT OFFERINGS
21.6. DIASORIN S.P.A.
21.6.1. BUSINESS OVERVIEW
21.6.2. PRODUCT OFFERINGS
21.7. F. HOFFMANN-LA ROCHE
21.7.1. BUSINESS OVERVIEW
21.7.2. PRODUCT OFFERINGS
21.8. HARDY DIAGNOSTICS
21.8.1. BUSINESS OVERVIEW
21.8.2. PRODUCT OFFERINGS
21.9. HIMEDIA LABORATORIES
21.9.1. BUSINESS OVERVIEW
21.9.2. PRODUCT OFFERINGS
21.10. ITL BIOMEDICAL
21.10.1. BUSINESS OVERVIEW
21.10.2. PRODUCT OFFERINGS
21.11. KURIN INC
21.11.1. BUSINESS OVERVIEW
21.11.2. PRODUCT OFFERINGS
21.12. LABOTRONICS SCIENTIFIC
21.12.1. BUSINESS OVERVIEW
21.12.2. PRODUCT OFFERINGS
21.13. MEDITEC TECHNOLOGIES INDIA PRIVATE LIMITED
21.13.1. BUSINESS OVERVIEW
21.13.2. PRODUCT OFFERINGS
21.14. OPGEN
21.14.1. BUSINESS OVERVIEW
21.14.2. PRODUCT OFFERINGS
21.15. RENDER BIOTECH CO., LTD
21.15.1. BUSINESS OVERVIEW
21.15.2. PRODUCT OFFERINGS
21.16. SARSTEDT AG & CO KG
21.16.1. BUSINESS OVERVIEW
21.16.2. PRODUCT OFFERINGS
21.17. SIEMENS HEALTHINEERS AG
21.17.1. BUSINESS OVERVIEW
21.17.2. PRODUCT OFFERINGS
21.18. SCENKER BIOLOGICAL TECHNOLOGY CO., LTD
21.18.1. BUSINESS OVERVIEW
21.18.2. PRODUCT OFFERINGS
21.19. T2 BIOSYSTEMS (T2BIO)
21.19.1. BUSINESS OVERVIEW
21.19.2. PRODUCT OFFERINGS
22 REPORT SUMMARY
22.1. KEY TAKEAWAYS
22.2. STRATEGIC RECOMMENDATIONS
23 QUANTITATIVE SUMMARY
23.1. MARKET BY SAMPLE TYPE
23.2. MARKET BY METHOD
23.3. MARKET BY PRODUCT
23.4. MARKET BY END-USER
23.5. MARKET BY GEOGRAPHY
23.6. SAMPLE TYPE: MARKET BY GEOGRAPHY
23.6.1. BACTERIAL SAMPLE: MARKET BY GEOGRAPHY
23.6.2. NON-BACTERIAL SAMPLE: MARKET BY GEOGRAPHY
23.7. METHOD: MARKET BY GEOGRAPHY
23.7.1. MANUAL/CONVENTIONAL BLOOD CULTURE: MARKET BY GEOGRAPHY
23.7.2. AUTOMATED BLOOD CULTURE: MARKET BY GEOGRAPHY
23.8. PRODUCT: MARKET BY GEOGRAPHY
23.8.1. CONSUMABLES: MARKET BY GEOGRAPHY
23.8.2. TEST EQUIPMENT: MARKET BY GEOGRAPHY
23.9. END-USER: MARKET BY GEOGRAPHY
23.9.1. HOSPITAL-BASED LABORATORIES: MARKET BY GEOGRAPHY
23.9.2. CLINICAL LABORATORIES: MARKET BY GEOGRAPHY
23.9.3. ACADEMIC & RESEARCH LABORATORIES/CENTERS: MARKET BY GEOGRAPHY
23.9.4. OTHERS: MARKET BY GEOGRAPHY
24 APPENDIX
24.1. RESEARCH METHODOLOGY
24.2. RESEARCH PROCESS
24.3. REPORT ASSUMPTIONS & CAVEATS
24.3.1. KEY CAVEATS
24.3.2. CURRENCY CONVERSION
24.4. ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 DYNAMICS OF BLOOD CULTURE TESTS MARKET
EXHIBIT 3 GLOBAL BLOOD CULTURE TESTS MARKET BY SEGMENT
EXHIBIT 4 BLOOD CULTURE TESTS ARE RECOMMENDED TO IDENTIFY
EXHIBIT 5 IMPACT OF GROWTH & DEVELOPMENT IN BLOOD CULTURE PATHWAY
EXHIBIT 6 KEY RECOMMENDATION BY NHS ENGLAND TO IMPROVE BLOOD CULTURE PATHWAYS
EXHIBIT 7 BLOOD CULTURE CONTAMINATION RATE BEFORE & AFTER INTERVENTION IN SAUDI ARABIA (2020- 2021)
EXHIBIT 8 IMPACT OF RISING DEVELOPMENT WITH AUTOMATED BLOOD CULTURE TESTS
EXHIBIT 9 IMPACT OF ADVANCES IN BLOOD CULTURE TESTING
EXHIBIT 10 AVAILABLE MOLECULAR METHODS FOR POSITIVE BLOOD CULTURES
EXHIBIT 11 IMPACT OF INCREASE IN PREVALENCE OF SEPSIS
EXHIBIT 12 SEPSIS PREVALENCE 2022
EXHIBIT 13 IMPACT OF RISE IN BURDEN OF BLOODSTREAM INFECTIONS
EXHIBIT 14 BLOODSTREAM INFECTIONS
EXHIBIT 15 IMPACT OF INCREASE IN DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
EXHIBIT 16 IMPACT OF CONTAMINATION IS MAJOR CHALLENGE FOR BLOOD CULTURE TESTS
EXHIBIT 17 CONSEQUENCES OF BLOOD CULTURE CONTAMINATION
EXHIBIT 18 IMPACT OF FALSE POSITIVE & NEGATIVE ERRORS AND ASSOCIATED IMPACTS
EXHIBIT 19 IMPACT OF FALSE POSITIVE BLOOD CULTURE RESULTS (2022)
EXHIBIT 20 IMPACT OF ALTERNATIVES TO BLOOD CULTURE TESTS
EXHIBIT 21 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023-2029
EXHIBIT 22 GLOBAL BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 23 GLOBAL BLOOD CULTURE TESTS MARKET BY SEGMENT
EXHIBIT 24 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE
EXHIBIT 25 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD
EXHIBIT 26 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT
EXHIBIT 27 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER
EXHIBIT 28 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY
EXHIBIT 29 FIVE FORCES ANALYSIS 2023
EXHIBIT 30 INCREMENTAL GROWTH BY SAMPLE TYPE 2023 & 2029
EXHIBIT 31 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023-2029
EXHIBIT 32 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE: INCREMENTAL GROWTH
EXHIBIT 33 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE: ABSOLUTE GROWTH
EXHIBIT 34 BLOODSTREAM INFECTION CAUSING BACTERIAL PATHOGENS (1997-2019) (%)
EXHIBIT 35 GLOBAL BLOOD CULTURE TESTS MARKET BY BACTERIAL SAMPLE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 37 GLOBAL BLOOD CULTURE TESTS MARKET BY NON-BACTERIAL SAMPLE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY METHOD 2023 & 2029
EXHIBIT 40 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD 2023-2029
EXHIBIT 41 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD: INCREMENTAL GROWTH
EXHIBIT 42 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD: ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL BLOOD CULTURE TESTS MARKET BY MANUAL/CONVENTIONAL BLOOD CULTURE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 45 ADVANTAGES OF AUTOMATED BLOOD CULTURE
EXHIBIT 46 GLOBAL BLOOD CULTURE TESTS MARKET BY AUTOMATED BLOOD CULTURE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY PRODUCT 2023 & 2029
EXHIBIT 49 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT 2023-2029
EXHIBIT 50 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 51 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 52 CONSUMABLES REQUIRED IN BLOOD CULTURE TESTS
EXHIBIT 53 GLOBAL BLOOD CULTURE TESTS MARKET BY CONSUMABLES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET 2020-2029 ($ BILLION)
EXHIBIT 55 GLOBAL BLOOD CULTURE TESTS MARKET BY TEST EQUIPMENT: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET 2020-2029 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 58 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER 2023-2029
EXHIBIT 59 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 60 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL BLOOD CULTURE TESTS MARKET BY HOSPITAL-BASED LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 63 GLOBAL BLOOD CULTURE TESTS MARKET BY CLINICAL LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 65 GLOBAL BLOOD CULTURE TESTS MARKET BY ACADEMIC & RESEARCH LABORATORIES/CENTERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 67 GLOBAL BLOOD CULTURE TESTS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 70 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023-2029
EXHIBIT 71 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 72 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 73 KEY COUNTRIES IN NORTH AMERICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 74 NORTH AMERICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 NORTH AMERICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 77 SEPSIS STATISTICS IN US 2022
EXHIBIT 78 US BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 79 BLOODSTREAM INFECTION CASES BY HEALTHCARE SETTINGS (2022)
EXHIBIT 80 CANADA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 81 EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES GUIDELINES (2012)
EXHIBIT 82 KEY COUNTRIES IN EUROPE BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 83 EUROPE BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 84 EUROPE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 85 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 86 GERMANY BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 87 FRANCE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 88 RECOMMENDATIONS BY NHS ENGLAND TO IMPROVE BLOOD CULTURE PATHWAY
EXHIBIT 89 UK BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 90 ITALY BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 91 SPAIN BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 92 RUSSIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 93 POLAND BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 94 KEY COUNTRIES IN APAC BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 95 SEPSIS PREVALENCE IN ASIAN COUNTRIES BY INCOME GROUP (2020)
EXHIBIT 96 APAC BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 97 APAC BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 98 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 99 CHINA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 100 INDIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 101 JAPAN BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 102 SOUTH KOREA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 103 AUSTRALIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 104 INDONESIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 105 KEY COUNTRIES IN LATIN AMERICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 106 LATIN AMERICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 107 LATIN AMERICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 109 BRAZIL BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 110 MEXICO BLOOD CULTURE TESTS MARKET 2023-2029 ($ BILLION)
EXHIBIT 111 ARGENTINA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 112 KEY COUNTRIES IN MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 113 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 114 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 115 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 116 EPIDEMIOLOGY & PREVALENCE OF SEPSIS IN ICUS IN TURKEY (2020)
EXHIBIT 117 TURKEY BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 118 SAUDI ARABIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 119 SOUTH AFRICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 120 UAE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 121 MARKET DOMINANCE ANALYSIS OF VENDORS OFFERING BLOOD CULTURE TESTS
EXHIBIT 122 CAPABILITIES & EXPERT ASSESSMENT OF VENDORS OFFERING BLOOD CULTURE TESTS
EXHIBIT 123 ANNUAL REVENUE OF BD 2021-2023 ($ BILLION)
EXHIBIT 124 ANNUAL REVENUE OF BD BY GEOGRAPHY 2023 (%)
EXHIBIT 125 ANNUAL REVENUE OF BIOMERIEUX 2020-2022 ($ MILLION)
EXHIBIT 126 ANNUAL REVENUE OF BIOMERIEUX BY GEOGRAPHY 2022 (%)
EXHIBIT 127 ANNUAL REVENUE OF BRUKER 2020-2022 ($ BILLION)
EXHIBIT 128 ANNUAL REVENUE OF DANAHER 2020-2022 ($ BILLION)
EXHIBIT 129 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC 2020-2022 ($ BILLION)
EXHIBIT 130 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC BY SEGMENT 2022 (%)
EXHIBIT 131 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC BY GEOGRAPHY 2022 (%)
EXHIBIT 132 KEY CAVEATS
LIST OF EXHIBITS
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 DYNAMICS OF BLOOD CULTURE TESTS MARKET
EXHIBIT 3 GLOBAL BLOOD CULTURE TESTS MARKET BY SEGMENT
EXHIBIT 4 BLOOD CULTURE TESTS ARE RECOMMENDED TO IDENTIFY
EXHIBIT 5 IMPACT OF GROWTH & DEVELOPMENT IN BLOOD CULTURE PATHWAY
EXHIBIT 6 KEY RECOMMENDATION BY NHS ENGLAND TO IMPROVE BLOOD CULTURE PATHWAYS
EXHIBIT 7 BLOOD CULTURE CONTAMINATION RATE BEFORE & AFTER INTERVENTION IN SAUDI ARABIA (2020- 2021)
EXHIBIT 8 IMPACT OF RISING DEVELOPMENT WITH AUTOMATED BLOOD CULTURE TESTS
EXHIBIT 9 IMPACT OF ADVANCES IN BLOOD CULTURE TESTING
EXHIBIT 10 AVAILABLE MOLECULAR METHODS FOR POSITIVE BLOOD CULTURES
EXHIBIT 11 IMPACT OF INCREASE IN PREVALENCE OF SEPSIS
EXHIBIT 12 SEPSIS PREVALENCE 2022
EXHIBIT 13 IMPACT OF RISE IN BURDEN OF BLOODSTREAM INFECTIONS
EXHIBIT 14 BLOODSTREAM INFECTIONS
EXHIBIT 15 IMPACT OF INCREASE IN DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
EXHIBIT 16 IMPACT OF CONTAMINATION IS MAJOR CHALLENGE FOR BLOOD CULTURE TESTS
EXHIBIT 17 CONSEQUENCES OF BLOOD CULTURE CONTAMINATION
EXHIBIT 18 IMPACT OF FALSE POSITIVE & NEGATIVE ERRORS AND ASSOCIATED IMPACTS
EXHIBIT 19 IMPACT OF FALSE POSITIVE BLOOD CULTURE RESULTS (2022)
EXHIBIT 20 IMPACT OF ALTERNATIVES TO BLOOD CULTURE TESTS
EXHIBIT 21 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023-2029
EXHIBIT 22 GLOBAL BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 23 GLOBAL BLOOD CULTURE TESTS MARKET BY SEGMENT
EXHIBIT 24 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE
EXHIBIT 25 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD
EXHIBIT 26 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT
EXHIBIT 27 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER
EXHIBIT 28 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY
EXHIBIT 29 FIVE FORCES ANALYSIS 2023
EXHIBIT 30 INCREMENTAL GROWTH BY SAMPLE TYPE 2023 & 2029
EXHIBIT 31 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023-2029
EXHIBIT 32 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE: INCREMENTAL GROWTH
EXHIBIT 33 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE: ABSOLUTE GROWTH
EXHIBIT 34 BLOODSTREAM INFECTION CAUSING BACTERIAL PATHOGENS (1997-2019) (%)
EXHIBIT 35 GLOBAL BLOOD CULTURE TESTS MARKET BY BACTERIAL SAMPLE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 37 GLOBAL BLOOD CULTURE TESTS MARKET BY NON-BACTERIAL SAMPLE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY METHOD 2023 & 2029
EXHIBIT 40 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD 2023-2029
EXHIBIT 41 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD: INCREMENTAL GROWTH
EXHIBIT 42 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD: ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL BLOOD CULTURE TESTS MARKET BY MANUAL/CONVENTIONAL BLOOD CULTURE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 45 ADVANTAGES OF AUTOMATED BLOOD CULTURE
EXHIBIT 46 GLOBAL BLOOD CULTURE TESTS MARKET BY AUTOMATED BLOOD CULTURE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY PRODUCT 2023 & 2029
EXHIBIT 49 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT 2023-2029
EXHIBIT 50 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 51 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 52 CONSUMABLES REQUIRED IN BLOOD CULTURE TESTS
EXHIBIT 53 GLOBAL BLOOD CULTURE TESTS MARKET BY CONSUMABLES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET 2020-2029 ($ BILLION)
EXHIBIT 55 GLOBAL BLOOD CULTURE TESTS MARKET BY TEST EQUIPMENT: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET 2020-2029 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 58 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER 2023-2029
EXHIBIT 59 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 60 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL BLOOD CULTURE TESTS MARKET BY HOSPITAL-BASED LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 63 GLOBAL BLOOD CULTURE TESTS MARKET BY CLINICAL LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 65 GLOBAL BLOOD CULTURE TESTS MARKET BY ACADEMIC & RESEARCH LABORATORIES/CENTERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 67 GLOBAL BLOOD CULTURE TESTS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 70 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023-2029
EXHIBIT 71 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 72 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 73 KEY COUNTRIES IN NORTH AMERICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 74 NORTH AMERICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 NORTH AMERICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 77 SEPSIS STATISTICS IN US 2022
EXHIBIT 78 US BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 79 BLOODSTREAM INFECTION CASES BY HEALTHCARE SETTINGS (2022)
EXHIBIT 80 CANADA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 81 EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES GUIDELINES (2012)
EXHIBIT 82 KEY COUNTRIES IN EUROPE BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 83 EUROPE BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 84 EUROPE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 85 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 86 GERMANY BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 87 FRANCE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 88 RECOMMENDATIONS BY NHS ENGLAND TO IMPROVE BLOOD CULTURE PATHWAY
EXHIBIT 89 UK BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 90 ITALY BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 91 SPAIN BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 92 RUSSIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 93 POLAND BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 94 KEY COUNTRIES IN APAC BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 95 SEPSIS PREVALENCE IN ASIAN COUNTRIES BY INCOME GROUP (2020)
EXHIBIT 96 APAC BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 97 APAC BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 98 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 99 CHINA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 100 INDIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 101 JAPAN BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 102 SOUTH KOREA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 103 AUSTRALIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 104 INDONESIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 105 KEY COUNTRIES IN LATIN AMERICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 106 LATIN AMERICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 107 LATIN AMERICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 109 BRAZIL BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 110 MEXICO BLOOD CULTURE TESTS MARKET 2023-2029 ($ BILLION)
EXHIBIT 111 ARGENTINA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 112 KEY COUNTRIES IN MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 113 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 114 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 115 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 116 EPIDEMIOLOGY & PREVALENCE OF SEPSIS IN ICUS IN TURKEY (2020)
EXHIBIT 117 TURKEY BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 118 SAUDI ARABIA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 119 SOUTH AFRICA BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 120 UAE BLOOD CULTURE TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 121 MARKET DOMINANCE ANALYSIS OF VENDORS OFFERING BLOOD CULTURE TESTS
EXHIBIT 122 CAPABILITIES & EXPERT ASSESSMENT OF VENDORS OFFERING BLOOD CULTURE TESTS
EXHIBIT 123 ANNUAL REVENUE OF BD 2021-2023 ($ BILLION)
EXHIBIT 124 ANNUAL REVENUE OF BD BY GEOGRAPHY 2023 (%)
EXHIBIT 125 ANNUAL REVENUE OF BIOMERIEUX 2020-2022 ($ MILLION)
EXHIBIT 126 ANNUAL REVENUE OF BIOMERIEUX BY GEOGRAPHY 2022 (%)
EXHIBIT 127 ANNUAL REVENUE OF BRUKER 2020-2022 ($ BILLION)
EXHIBIT 128 ANNUAL REVENUE OF DANAHER 2020-2022 ($ BILLION)
EXHIBIT 129 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC 2020-2022 ($ BILLION)
EXHIBIT 130 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC BY SEGMENT 2022 (%)
EXHIBIT 131 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC BY GEOGRAPHY 2022 (%)
EXHIBIT 132 KEY CAVEATS
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.